2024
Association of Hospitalist Care and Outcomes for Patients Electively Admitted for Chemotherapy
Vaughn J, Morris J, Merl M, Gould Rothberg BE. Association of Hospitalist Care and Outcomes for Patients Electively Admitted for Chemotherapy. Journal Of Brown Hospital Medicine 2024, 3 DOI: 10.56305/001c.115906.Peer-Reviewed Original ResearchLength of stayAnticancer therapyHematologic malignanciesHospitalist careBlood cell count recoveryTumor lysis syndromeQuality outcomesMean discharge timeEfficiency of careOutcomes of length of stayMixed linear regression modelsCount recoveryCare of patientsMethotrexate clearanceTherapy initiationTherapy regimenNo significant differenceTherapy administrationPatientsLinear regression modelsMean timeTherapySignificant differenceImprove qualityMalignancy
2023
Association of Hospitalist Care and Outcomes on an Inpatient Elective Anticancer Therapy Service
Vaughn J, Merl M, Morris J, Rothberg BE. Association of Hospitalist Care and Outcomes on an Inpatient Elective Anticancer Therapy Service. Blood 2023, 142: 2335. DOI: 10.1182/blood-2023-190824.Peer-Reviewed Original ResearchHospitalist careTherapy administrationRace/ethnicityTherapy servicesIllness indexSmilow Cancer HospitalTumor lysis syndromeMean discharge timeSignificant differencesQuality outcomesIndex regimenLysis syndromeMedian ageAnticancer regimenMultiple admissionsMethotrexate clearanceCancer HospitalCancer CenterTreatment daysTherapy typeDay 1PatientsAdmissionLymphomaTherapy team
2021
Survival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017)
Vaughn J, Pinheiro L, Olszewski A, Epperla N. Survival of patients with marginal zone lymphoma in the United States: A population‐based cohort study (2000 to 2017). American Journal Of Hematology 2021, 96: e123-e126. PMID: 33476433, DOI: 10.1002/ajh.26103.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAgedAged, 80 and overAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesConfounding Factors, EpidemiologicFemaleHumansKaplan-Meier EstimateLymphoma, B-Cell, Marginal ZoneMaleMiddle AgedMortalityPrognosisRituximabSEER ProgramSocial Determinants of HealthUnited StatesYoung Adult
2020
Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus
Gkrouzman E, Smith M, Ghosh N, Laurence J, Seshan S, Vaughn J, Levine A, Bass A, Erkan D. Recurrent Complement-Mediated Thrombotic Microangiopathy in a Patient with Systemic Lupus Erythematosus. HSS Journal ® 2020, 16: 507-514. PMID: 33380989, PMCID: PMC7749916, DOI: 10.1007/s11420-020-09761-9.Peer-Reviewed Original Research